Skip to content
healthcare.dev
Get a free key

Pepto Relief

NDC 17714-045, Bismuth subsalicylate, tablet, chewable, from Advance Pharmaceutical Inc..

Product NDC
17714-045
Status
Listed
Labeler
Advance Pharmaceutical Inc.
Dosage form
TABLET, CHEWABLE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH FINAL
Application
part335
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/17714-045 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BISMUTH SUBSALICYLATE262 mg/1

Pharmacologic classes

Bismuth [CS]; Bismuth [EPC]

Package NDCNDC-11Package
17714-045-301771400453030 TABLET, CHEWABLE in 1 BOTTLE (17714-045-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 17714-045 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/17714-045 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 17714-045. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.